Reform and recalibration

Germany legalises adult use (2024) as Thailand returns to a medical-only model (2025). In 2026 the United States reclassifies FDA-approved and state-licensed medical cannabis to Schedule III — a first crack in federal prohibition, though recreational cannabis remains Schedule I.